Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Medical Condition: Breast cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+cancer%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+cancer%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Breast+cancer%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (28)
1
Phase Ib/II clinical trial of RC48-ADC in combination with pyrotinib in HER2-positive recurrent or metastatic breast cancer after trastuzumab failure : Phase Ib/II clinical trial of RC48-ADC in combination with pyrotinib in HER2-positive recurrent or metastatic breast cancer after trastuzumab failure
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Phase Ib/II clinical trial of RC48-ADC in combination with pyrotinib in HER2-positive recurrent or metastatic breast cancer after trastuzumab failure : Phase Ib/II clinical trial of RC48-ADC in combination with pyrotinib in HER2-positive recurrent or metastatic breast cancer after trastuzumab failure
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Dalpiciclib and letrozole combined with trastuzumab / pertuzumab in neoadjuvant treatment of stage II-III HR positive HER2 positive breast cancer: a phase Ib/II study : Dalpiciclib and letrozole combined with trastuzumab / pertuzumab in neoadjuvant treatment of stage II-III HR positive HER2 positive breast cancer: a phase Ib/II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Dalpiciclib and letrozole combined with trastuzumab / pertuzumab in neoadjuvant treatment of stage II-III HR positive HER2 positive breast cancer: a phase Ib/II study : Dalpiciclib and letrozole combined with trastuzumab / pertuzumab in neoadjuvant treatment of stage II-III HR positive HER2 positive breast cancer: a phase Ib/II study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR+/HER2- Advanced Breast Cancer : Study to Evaluate the Efficacy and Safety of Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR+/HER2- Advanced Breast Cancer : Study to Evaluate the Efficacy and Safety of Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Clinical study of in vivo optic imaging of breast cancer using diffuse optic spectroscopy : Clinical study of in vivo optic imaging of breast cancer using diffuse optic spectroscopy - Breast cancer imaging using diffuse optic spectroscopy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Development of New Diagnostic Method of Sentinel Lymph Nodes and Surgical Margins Using 5-Aminolevulinic Acid in Breast Cancer Patients. : Development of New Diagnostic Method of Sentinel Lymph Nodes and Surgical Margins Using 5-Aminolevulinic Acid in Breast Cancer Patients. - Diagnosis of Sentinel Lymph Nodes and Surgical Margins Using 5-Aminolevulinic Acid in Breast Cancer Patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A phase I/II study of proton beam therapy for early breast cancer evaluating safety and effectiveness : A phase I/II study of proton beam therapy for early breast cancer evaluating safety and effectiveness - A phase I/II study of proton beam therapy for early breast cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
oral CEF(Cyclophosphamide, Epirubicin, UFT) adjuvant chemotherapy for breast cancer with intra-patient dose escalation : oral CEF(Cyclophosphamide, Epirubicin, UFT) adjuvant chemotherapy for breast cancer with intra-patient dose escalation - Oral CEF adjuvant chemotherapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Medical Condition: Breast cancer
Medienart
28
Aufsätze
28
E-Artikel
28
E-Ressourcen
Zeitschriftentitel
28
WHO International Clinical Trials Registry Plat...
Thema
28
610
Medical Condition: Breast cancer
Phase: Phase 1/Phase 2
22
Study Type: Interventional
10
Recruitment Status: Complete: follow-up complete
10
Recruitment Status: Recruiting
4
Recruitment Status: Not yet recruiting
4
Study Type: Observational
2
Recruitment Status: Complete: follow-up continuing
2
Recruitment Status: Suspended
2
Study Type: Interventional,observational
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
26
2020-
2
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
28
Englisch
Haven't found what you're looking for?
Wird geladen...